Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD

por Aaron, Shawn D, Vandemheen, Katherine L, Ramsay, Timothy, Zhang, Chun, Avnur, Zafrira, Nikolcheva, Tania, Quinn, Anthony
Publicado 2010

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

por Mattsson, Niklas, Carrillo, Maria C., Dean, Robert A., Devous, Michael D., Nikolcheva, Tania, Pesini, Pedro, Salter, Hugh, Potter, William Z., Sperling, Reisa S., Bateman, Randall J., Bain, Lisa J., Liu, Enchi
Publicado 2015

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

por Ostrowitzki, Susanne, Lasser, Robert A., Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory, Andjelkovic, Mirjana, Dubois, Bruno, Boada, Mercè, Blennow, Kaj, Santarelli, Luca, Fontoura, Paulo
Publicado 2017

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

por Ostrowitzki, Susanne, Lasser, Robert A., Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory, Andjelkovic, Mirjana, Dubois, Bruno, Boada, Mercè, Blennow, Kaj, Santarelli, Luca, Fontoura, Paulo
Publicado 2018

Deconvoluting Post-Transplant Immunity: Cell Subset-Specific Mapping Reveals Pathways for Activation and Expansion of Memory T, Monocytes and B Cells

por Grigoryev, Yevgeniy A., Kurian, Sunil M., Avnur, Zafi, Borie, Dominic, Deng, Jun, Campbell, Daniel, Sung, Joanna, Nikolcheva, Tania, Quinn, Anthony, Schulman, Howard, Peng, Stanford L., Schaffer, Randolph, Fisher, Jonathan, Mondala, Tony, Head, Steven, Flechner, Stuart M., Kantor, Aaron B., Marsh, Christopher, Salomon, Daniel R.
Publicado 2010

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

por Nave, Stephane, Doody, Rachelle S., Boada, Mercè, Grimmer, Timo, Savola, Juha-Matti, Delmar, Paul, Pauly-Evers, Meike, Nikolcheva, Tania, Czech, Christian, Borroni, Edilio, Ricci, Benedicte, Dukart, Juergen, Mannino, Marie, Carey, Tracie, Moran, Emma, Gilaberte, Inma, Muelhardt, Nicoletta Milani, Gerlach, Irene, Santarelli, Luca, Ostrowitzki, Susanne, Fontoura, Paulo
Publicado 2017

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

por Pagano, Gennaro, Boess, Frank G., Taylor, Kirsten I., Ricci, Benedicte, Mollenhauer, Brit, Poewe, Werner, Boulay, Anne, Anzures-Cabrera, Judith, Vogt, Annamarie, Marchesi, Maddalena, Post, Anke, Nikolcheva, Tania, Kinney, Gene G., Zago, Wagner M., Ness, Daniel K., Svoboda, Hanno, Britschgi, Markus, Ostrowitzki, Susanne, Simuni, Tanya, Marek, Kenneth, Koller, Martin, Sevigny, Jeff, Doody, Rachelle, Fontoura, Paulo, Umbricht, Daniel, Bonni, Azad
Publicado 2021